Dr. Batchelor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16455 Statesville Rd
Suite 360
Huntersville, NC 28078Phone+1 704-801-3300Fax+1 704-896-0599
Summary
- Dr. Thomas Batchelor is an internist in Huntersville, NC and is affiliated with multiple Atrium Health hospitals in the area. He received his medical degree from the University of Virginia School of Medicine. He completed residency and chief residency at Emory University. He has been in practice for 27 years.
Education & Training
- Emory University School of MedicineChief Residency, Internal Medicine, 1997 - 1998
- Emory University School of MedicineResidency, Internal Medicine, 1994 - 1997
- University of Virginia School of MedicineClass of 1994
Certifications & Licensure
- NC State Medical License 1998 - 2026
- SC State Medical License 2007 - 2009
- GA State Medical License 1995 - 1999
- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Charlotte Magazine Top Doctors Charlotte Magazine, 2012-2013, 2017, 2020-2021, 2023-2024
- Teal Acorn Innovator of the Year, Finalist Atrium Health, 2021
- Pinnacle Award Finalist Atrium Health, 2020
- Join now to see all
Publications & Presentations
PubMed
- 63 citationsInsights From Rapid Deployment of a "Virtual Hospital" as Standard Care During the COVID-19 Pandemic.Kranthi Sitammagari, Stephanie Murphy, Marc A. Kowalkowski, Shih-Hsiung Chou, Matthew Sullivan
Annals of Internal Medicine. 2021-02-01
Journal Articles
- Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysisT Bachelor, Journal of the American Society of Nephrology 7(11):2399-402 · November 1996, 11/1996
Press Mentions
- Novo Holdings Co-Leads Hemab’s USD55m Series AJuly 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: